Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Multicenter and Observational Study of Osimertinib Monotherapy Treatment in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive Who Have Received the Treatment Within the Special Use Medication Program in Spain

NCT03790397 is registered in ClinicalTrials.gov with Fundación GECP as lead sponsor.

NCT NCT03790397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03790397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Multicenter and Observational Study of Osimertinib Monotherapy Treatment in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive Who Have Received the Treatment Within the Special Use Medication Program in Spain
Lead sponsor
Fundación GECP
Phase
Observational
Overall status
Completed
Start date
February 26, 2019
Completion date
April 1, 2020
Enrollment
169 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer